A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

Εμφάνιση άλλων εκδόσεων (1)

We examined the safety, immunogenicity and efficacy of a prime-boost vaccination regime involving two poxvirus malaria subunit vaccines, FP9-PP and MVA-PP, expressing the same polyprotein consisting of six pre-erythrocytic antigens from Plasmodium falciparum. Following safety assessment of single do...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Porter, D, Thompson, F, Berthoud, T, Hutchings, C, Andrews, L, Biswas, S, Poulton, I, Prieur, E, Correa, S, Rowland, R, Lang, T, Williams, J, Gilbert, S, Sinden, R, Todryk, S, Hill, A
Μορφή: Journal article
Γλώσσα:English
Έκδοση: 2011

Παρόμοια τεκμήρια